New Intellectual Property Rights to ease Patent filing
The new Intellectual Property Rights policy in India seeks to make patent filing more accessible to Indian innovators. The policy highlights the need for legal reforms and targeted…
Patents
1,303 articles
True Position Inc.’s Device Locator Patent Invalidated
The USPTO’s PTAB has invalidated True Position Inc.’s device locator patent 7,783,299 on grounds of anticipation and obviousness based on prior art. Polaris Wireless successfully challenged the patent’s…
What makes Samsung want to buy Blackberry?
Samsung’s reported interest in acquiring Blackberry highlights the value of Blackberry’s patent portfolio and strategic assets. The potential deal faces regulatory scrutiny in Canada and could impact competition…
‘Killead’s Patent Application Killed by the Indian Patent Office!
Gilead’s patent for Sofosbuvir was rejected by the Indian Patent Office on grounds of insufficient therapeutic efficacy. This landmark decision enables wider access to affordable generic Hepatitis C…
Roche’s backbone rendered brittle by Indian Patent Office
The Indian Patent Office has revoked Roche’s patent on Bonviva after Cipla challenged its validity, citing a lack of inventive step and patentability. This decision highlights critical aspects…
Weekly IP Warm-UP!
Weekly IP Warm-UP covers notable intellectual property law updates, including copyright and patent litigation, music industry developments, and trade secrets cases. The post analyses recent legal changes and…
Drug Humira turns Rheumatic for Abbott Biotechnology
The Indian Patent Office set aside Abbott Biotechnology's Humira patent after Glenmark's pre-grant opposition, citing lack of inventive step and insufficient disclosure. This legal dispute underscores ongoing challenges…
Dr. Kalyan Quoted in the Indian Express
An article published in the Indian Express on 11/01/2015, titled “More Spends on Patents Needed”, examined the comparatively low number of patents filed by Indian companies relative to…
RPX acquires patents owned by Apple’s Rockstar Consortium for US$ 900M
RPX Corp. is acquiring around 4,000 patents from Apple’s Rockstar Consortium for US$ 900 million, effectively ending several major patent lawsuits. This deal highlights a move from litigation…
Astrazeneca to retain Sweetness of Onglyza
Astrazeneca has brought a patent infringement case against Aurobindo Pharma over an ANDA filing for Onglyza’s generic version in the US. The dispute centres on the alleged infringement…